Thu, January 17, 2013
Wed, January 16, 2013
Tue, January 15, 2013
Mon, January 14, 2013
Fri, January 11, 2013
Thu, January 10, 2013
Wed, January 9, 2013
Tue, January 8, 2013
Mon, January 7, 2013
Sun, January 6, 2013
Fri, January 4, 2013
Thu, January 3, 2013
Wed, January 2, 2013
Mon, December 31, 2012
Fri, December 28, 2012
Thu, December 27, 2012
Wed, December 26, 2012
[ Wed, Dec 26th 2012 ]: Market Wire
30 p.m. ET
Mon, December 24, 2012
Fri, December 21, 2012
Thu, December 20, 2012
[ Thu, Dec 20th 2012 ]: Market Wire
A View from the Top
[ Thu, Dec 20th 2012 ]: Market Wire
A Year Of Taking Action
Wed, December 19, 2012
Tue, December 18, 2012
Mon, December 17, 2012

Syneron to Present at 15th Annual Needham Growth Conference


  Copy link into your clipboard //health-fitness.news-articles.net/content/2013/ .. nt-at-15th-annual-needham-growth-conference.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

Syneron to Present at 15th Annual Needham Growth Conference -- YOKNEAM, Israel, Jan. 4, 2013 /PRNewswire/ --

YOKNEAM, Israel, Jan. 4, 2013 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: [ ELOS ]), the leading global aesthetic device company, announced today that Louis P. Scafuri , Chief Executive Officer, is scheduled to present at the 15th Annual Needham Growth Conference in New York City.

(Logo:  [ http://photos.prnewswire.com/prnh/20120528/535447 ])

Conference:   15th Annual Needham Growth Conference  
Date:               Tuesday, January 15, 2013
Time:              3:30 p.m. ET

The presentation will be webcast live over the Internet and can be accessed through the Investor Relations section on Syneron's website at [ www.investors.syneron.com ]. Please go to the website a few minutes early, as it may be necessary to download audio software to hear the presentation.

About Syneron Medical Ltd.
Syneron Medical Ltd. (NASDAQ: [ ELOS ]) is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The Company markets, services and supports its products in 90 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

SOURCE Syneron Medical Ltd.




Publication Contributing Sources